Stock Compensation and Earnings (Loss) per Share (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Restricted Stock Shares Activity |
Activity related to the Company’s equity compensation, which includes the Company’s restricted stock units (“RSUs”) and performance stock units (“PSUs”), was as follows:
| | | | | | | | | | | | | (in thousands, except weighted average grant price) | Number of Shares | | Weighted Average Grant Price | Outstanding awards, December 31, 2025 | 1,187 | | | $ | 15.39 | | | Granted | 732 | | | 13.44 | | | Vested | (503) | | | 15.82 | | | Forfeited | (22) | | | 14.61 | | Outstanding awards, June 30, 2026 | 1,394 | | | $ | 14.22 | |
Activity related to the Company’s Relative Total Shareholder Return RSUs (“RTSRs”) was as follows:
| | | | | | | | | | | | | (in thousands, except weighted average grant price) | Number of Shares | | Weighted Average Grant Price | Outstanding awards, December 31, 2025 | 360 | | | $ | 15.77 | | | Granted | 118 | | | 13.42 | | | Vested | — | | | — | | | Forfeited | — | | | — | | Outstanding awards, June 30, 2026 | 478 | | | $ | 15.19 | |
|
| Schedule of Stock Compensation Expense |
Stock-based compensation expense was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands) | | 2026 | | 2025 | | 2026 | | 2025 | | Stock compensation expense | | $ | 2,595 | | | $ | 2,493 | | | $ | 7,566 | | | $ | 6,390 | | | Capitalized stock compensation | | (292) | | | (306) | | | (465) | | | (486) | | | Stock compensation expense, net | | $ | 2,303 | | | $ | 2,187 | | | $ | 7,101 | | | $ | 5,904 | |
|
| Schedule of Earnings Per Share, Basic and Diluted |
The following table indicates the computation of basic and diluted earnings (loss) per share:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands, except per share amounts) | | 2026 | | 2025 | | 2026 | | 2025 | | Calculation of net loss income per share: | | | | | | | | | | Net loss | | $ | (7,699) | | | $ | (9,048) | | | $ | (23,450) | | | $ | (18,180) | | | | | | | | | | | Amounts attributable to common shareholders | | | | | | | | | Net loss attributable to common shareholders | | $ | (9,304) | | | $ | (10,545) | | | $ | (26,632) | | | $ | (21,149) | | | | | | | | | | | | Basic and diluted weighted average shares outstanding | | 55,779 | | | 55,103 | | | 55,664 | | | 55,032 | | | | | | | | | | | Per share amounts attributable to common shareholders | | | | | | | | | | Net loss per share | | $ | (0.17) | | | $ | (0.19) | | | $ | (0.48) | | | $ | (0.38) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following table presents potentially dilutive instruments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands) | | 2026 | | 2025 | | 2026 | | 2025 | Potentially dilutive shares related to the Series A Preferred Stock | | 3,809 | | | 3,553 | | | 3,808 | | | 3,553 | | Potentially dilutive equity awards | | 727 | | | 436 | | | 617 | | | 431 | | | Total potentially dilutive instruments | | 4,536 | | | 3,989 | | | 4,425 | | | 3,984 | |
|